179 related articles for article (PubMed ID: 34133386)
1. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
[TBL] [Abstract][Full Text] [Related]
3. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
Alali M; Mayampurath A; Dai Y; Bartlett AH
Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
[TBL] [Abstract][Full Text] [Related]
4. Association Between Depth of Neutropenia and Clinical Outcomes in Febrile Pediatric Cancer and/or Patients Undergoing Hematopoietic Stem-cell Transplantation.
Alali M; David MZ; Danziger-Isakov LA; Bartlett AH; Petty LA; Schwartz T; Pisano J
Pediatr Infect Dis J; 2020 Jul; 39(7):628-633. PubMed ID: 32176187
[TBL] [Abstract][Full Text] [Related]
5. Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia.
Thangthong J; Anugulruengkitt S; Lauhasurayotin S; Chiengthong K; Poparn H; Sosothikul D; Techavichit P
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3487-3492. PubMed ID: 33369443
[TBL] [Abstract][Full Text] [Related]
6. Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia.
Erbaş İC; Çakıl Güzin A; Özdem Alataş Ş; Karaoğlu Asrak H; Akans İ; Akyol Ş; Özlü C; Tüfekçi Ö; Yılmaz Ş; Ören H; Belet N
Turk J Haematol; 2023 Aug; 40(3):143-153. PubMed ID: 37525503
[TBL] [Abstract][Full Text] [Related]
7. Etiology and clinical course of febrile neutropenia in children with cancer.
Hakim H; Flynn PM; Knapp KM; Srivastava DK; Gaur AH
J Pediatr Hematol Oncol; 2009 Sep; 31(9):623-9. PubMed ID: 19644403
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antibiotics discontinuation during bone marrow suppression in childhood, adolescent and young adult patients with febrile neutropenia.
Kobayashi R; Matsushima S; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
J Microbiol Immunol Infect; 2021 Dec; 54(6):1056-1060. PubMed ID: 32800573
[TBL] [Abstract][Full Text] [Related]
9. A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
Kamonrattana R; Sathitsamitphong L; Choeyprasert W; Charoenkwan P; Natesirinilkul R; Fanhchaksai K
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2733-2737. PubMed ID: 31554370
[TBL] [Abstract][Full Text] [Related]
10. Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasms.
Obrová K; Grumaz S; Remely M; Czurda S; Krickl I; Herndlhofer S; Gleixner KV; Sperr WR; Größlinger L; Frank T; Andrade N; Egger-Matiqi T; Peters C; Engstler G; Dworzak M; Attarbaschi A; van Grotel M; van den Heuvel-Eibrink MM; Moiseev IS; Rogacheva Y; Zubarovskaya L; Zubarovskaya N; Pichler H; Lawitschka A; Koller E; Keil F; Valent P; Sohn K; Lion T
Am J Hematol; 2021 Jun; 96(6):719-726. PubMed ID: 33784434
[TBL] [Abstract][Full Text] [Related]
11. Early Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever.
Villanueva MA; August KJ
Pediatr Blood Cancer; 2016 Oct; 63(10):1829-33. PubMed ID: 27196265
[TBL] [Abstract][Full Text] [Related]
12. Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients.
Alali M; Prather C; Danziger-Isakov LA; Kussin ML; Khalifeh M; Al Othman N; Bartlett AH
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e702-e709. PubMed ID: 37494607
[TBL] [Abstract][Full Text] [Related]
13. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy.
Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tanihara A; Kanda Y
Infect Dis (Lond); 2017 Oct; 49(10):748-757. PubMed ID: 28631944
[TBL] [Abstract][Full Text] [Related]
15. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.
Stern A; Carrara E; Bitterman R; Yahav D; Leibovici L; Paul M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012184. PubMed ID: 30605229
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of guideline for treatment of febrile neutropenia in pediatric cancer at Siriraj Hospital.
Sanpakit K; Phuakpet K; Veerakul G; Narkbunnam N; Chokephaibulkit K
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S124-34. PubMed ID: 16858853
[TBL] [Abstract][Full Text] [Related]
17. Usefulness analysis of the 2018 ASCO/IDSA guideline for outpatient management of fever and neutropenia in adults treated for malignancy.
Hwang S; Kwon KT; Kim Y; Bae S; Chang HH; Kim SW; Yoo SS; Nam SY; Baek JH
Sci Rep; 2021 Sep; 11(1):9048. PubMed ID: 34526516
[TBL] [Abstract][Full Text] [Related]
18. Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients.
Sezgin G; Acipayam C; Ozkan A; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2014; 15(11):4549-53. PubMed ID: 24969883
[TBL] [Abstract][Full Text] [Related]
19. High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy.
El Kebbi O; Prather CS; Elmuti L; Khalifeh M; Alali M
Sci Rep; 2023 Apr; 13(1):5627. PubMed ID: 37024512
[TBL] [Abstract][Full Text] [Related]
20. Risk predictors for adverse outcome in pediatric febrile neutropenia: Single center experience from a low and middle-income country.
Prasad M; Chinnaswamy G; Arora B; Vora T; Hawaldar R; Banavali S
Indian J Cancer; 2014; 51(4):432-7. PubMed ID: 26842150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
